rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
2001-2-22
|
pubmed:abstractText |
To evaluate the feasibility and efficacy of concomitant boost radiotherapy (RT) plus cisplatin-based chemotherapy compared with standard fractionation RT for patients with advanced nasopharyngeal cancer.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0732-183X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
19
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1105-10
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11181675-Adolescent,
pubmed-meshheading:11181675-Adult,
pubmed-meshheading:11181675-Aged,
pubmed-meshheading:11181675-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:11181675-Chemotherapy, Adjuvant,
pubmed-meshheading:11181675-Cisplatin,
pubmed-meshheading:11181675-Combined Modality Therapy,
pubmed-meshheading:11181675-Disease-Free Survival,
pubmed-meshheading:11181675-Feasibility Studies,
pubmed-meshheading:11181675-Female,
pubmed-meshheading:11181675-Fluorouracil,
pubmed-meshheading:11181675-Humans,
pubmed-meshheading:11181675-Male,
pubmed-meshheading:11181675-Middle Aged,
pubmed-meshheading:11181675-Nasopharyngeal Neoplasms,
pubmed-meshheading:11181675-Neoplasm Staging,
pubmed-meshheading:11181675-Radiotherapy Dosage,
pubmed-meshheading:11181675-Survival Analysis
|
pubmed:year |
2001
|
pubmed:articleTitle |
Accelerated concomitant boost radiotherapy and chemotherapy for advanced nasopharyngeal carcinoma.
|
pubmed:affiliation |
Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. woldens@mskcc.org
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Research Support, Non-U.S. Gov't
|